Samy Meroueh

Samy Meroueh

Samy Meroueh develops small molecules that modulate the function of proteins that are considered undruggable, such as members of the RAS and Rho GTPase superfamily, transcription factors and co-activators such as Hippo pathway TEAD and YAP, and proteins involved in...
Chitra Subramanian

Chitra Subramanian

Chitra Subramanian is a biomedical research scientist with experience in preclinical drug development, technology licensing, and project management.
Mark Cohen

Mark Cohen

Mark Cohen was previously a professor of surgery and pharmacology at the University of Michigan, where he also served as the director of the Medical School Pathway of Excellence in Innovation and Entrepreneurship and the director of endocrine surgery research and...
Angad Mehta

Angad Mehta

The Mehta Lab is combining expertise in synthetic biology and synthetic chemistry to develop fundamentally novel, modular platforms to engineer selectivity in targeting cancers. They are using principles of directed evolution and biomolecule delivery platforms to...
Hee-Sun Han

Hee-Sun Han

Hee-Sun Han’s lab develops novel technologies integrating diverse chemical and physical principles to study intact, fully assembled biological systems with single cell/molecule resolution, at high throughput while retaining the spatial or environmental...
Kendrith Rowland

Kendrith Rowland

Kendrith M. Rowland is an oncologist at Carle Foundation Hospital and Carle Cancer Center. He manages Carle’s NCI Community Oncology Research Program, optimizing collaboration between cancer researchers and clinicians to improve cancer prevention efforts,...
Kai Zhang

Kai Zhang

Kai Zhang’s lab group studies how signal transduction regulates cell fate determination and how normal signaling processes are compromised in disease conditions. Using live cell imaging and optogenetic control of signal transduction, Zhang observes and perturbs...
Michael Spinella

Michael Spinella

Michael Spinella’s laboratory is focused on the molecular genetics of cancer, especially in the areas of mechanisms of tumorigenesis, cancer therapy, and drug resistance. One research focus is on uncovering mechanisms that account for the curability of...
Douglas Mitchell

Douglas Mitchell

Douglas Mitchell and his lab group have focused on understanding the chemical biology of natural products with early efforts focusing on thiazole/oxazole-containing peptides. The Mitchell lab is multidisciplinary and employs a combination of bioinformatics,...
David Kranz

David Kranz

David Kranz’s lab been involved for many years in the discovery of immunotherapeutic approaches to cancer. The research program he leads is focused on the structure, function, and engineering of T cell receptors. The Kranz lab is interested in understanding the...
Stephen Sligar

Stephen Sligar

Stephen Sligar has spent his professional career focused on the discovery, development, and use of chemical and biophysical tools to understand fundamental problems in biochemistry. Sligar’s lab developed the Nanodisc platform, which allows for the generation of a...
David Shapiro

David Shapiro

David Shapiro’s lab has spent over a decade studying estrogens, acting via estrogen receptor a (ERa), which plays a key role in most breast cancers. The Shapiro laboratory has leveraged its expertise in ERa action in cancer to identify new pathways of hormone action...